Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma
Conditions: Superficial Basal Cell Carcinoma; Nodular Basal Cell Carcinoma Intervention: Drug: AIV001 Sponsor: AiViva BioPharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials